We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Arcontech Group Plc | ARC | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.50 | 0.40% | 125.50 | 12:18:39 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 125.00 | 125.00 | 125.50 | 125.50 | 125.00 |
| Industry Sector |
|---|
| SOFTWARE & COMPUTER SERVICES |
| Announcement Date | Type | Currency | Dividend Amount | Ex Date | Record Date | Payment Date |
|---|---|---|---|---|---|---|
| 02/09/2024 | Final | GBP | 0.0375 | 03/10/2024 | 04/10/2024 | 01/11/2024 |
| 05/09/2023 | Final | GBP | 0.035 | 05/10/2023 | 06/10/2023 | 03/11/2023 |
| 12/09/2022 | Final | GBP | 0.0325 | 29/09/2022 | 30/09/2022 | 24/10/2022 |
| 01/09/2021 | Final | GBP | 0.0275 | 09/09/2021 | 10/09/2021 | 08/10/2021 |
| 02/09/2020 | Final | GBP | 0.025 | 10/09/2020 | 11/09/2020 | 09/10/2020 |
| Top Posts |
|---|
Posted at 07/11/2024 14:10 by bones More often than not, a mystery rise with a flurry of small buyers is the result of a tip. I don’t have access to Investors Chronicle but Simon Thompson has been a fan of ARC for a while. Maybe he said something this week? I’ve checked Shares mag (via AJ Bell) and there a no mention I can see in today’s issue. I’m not complaining! |
Posted at 08/10/2024 14:14 by spig69 I also think the future is rosy and am happy to continue holding for the longer term as the share price, with a bit of good news, should well exceed the recent highs achieved. Throw in the progressive dividend policy and all that cash on hand, this is one of my more exciting and profitable shares to hold. I will re-invest my dividends early next month regardless of the price. |
Posted at 08/10/2024 12:46 by bones I’m now unlikely to make the AGM tomorrow.As for the share action, it is very ARC to see a determined rise be followed by a gradual drift down and that seems to have flushed out a few sellers who didn’t want to sell when the price was much higher even though nothing has changed. Perhaps some people are playing safe ahead of various rumours about the 30/10 govt budget. I’m very positive here. Reading the board’s notes from the last RNS, it is a volley of positivity about the company’s improved prospects and surprisingly upbeat given their conservative nature to pronouncements! I was particularly taken by the talk of soon having a full package to offer clients in competition with the other data suppliers rather than being a provider of add-ons. That has much potential especially as they noted how clients are using cost as a sufficient reason to switch despite the short term inconveniences. |
Posted at 10/9/2024 18:10 by bones The cash balance is big now and suggests they should do something with it. They often talk of looking at acquisitions but usually say nothing fits their requirements. I’m not sure how serious they really are as it rarely happens. So, how about a special dividend or buy back? Maybe if the next year produces the growth they hope will materialise?I recall ZYT which used to have a humongous cash accumulation and they never used it well. Earned low interest and their business matured and withered. That was a case of an established “old” management not having a dynamic approach to business or reacting when things went sour. I do think the cash in ARC should be put to better use soon. 5% interest doesn’t rock many boats. I hope the management are not too fusty and accustomed to their comfy surroundings! |
Posted at 10/9/2024 17:56 by bones Sounds like a plan gleach! What really prompted the post was how similar this stock is to TRD. Embedded management, no fund raises, steady “boring” business model, rock solid integrity, specific markets, illiquid share that’s rarely publicised.In late 2023, the chairman of TRD spoke glowingly of prospects after a long period of flat business. There was barely an RNS raised after that yet the share price silently went from 100p area to 300p (with a few ups and downs) and on unspectacular volume. The minute the ARC results were out last week, I could picture a similar scenario and piled in. So far so good but I think early days. I can see 200p easily and maybe 300p on a follow up positive trading update. |
Posted at 10/9/2024 16:40 by bones A little comparison exercise.The final results in the 2019 year were the last reasonably upbeat ones before the twin hammer of Brexit and Covid hit in early 2020. Since then, the business has struggled to gain traction and chugged along fitfully. 2024’s final results seemed to snap the spell with both an increase in numbers and a much improved outlook. To compare: Final results 2019 (last ones before Covid downturn): Financial Highlights: Revenue: £ 2,966,788 Profit before tax: £ 900,357 (excluding accruals adjustment) Cash: £ 4,063,484 Diluted EPS: 7.18p Final dividend per share: 2.00p Final results 2024 (first ones indicating a rosier outlook since Covid downturn): Financial Highlights: Revenue: £ 2,910,232 Profit before tax: £ 1,098,959 (no accruals adjustment in year) Cash: £ 7,160,177 Diluted EPS: 7.98p Final dividend per share: 3.75p Similar revenues and EPS numbers (shares in issue static at around 13.3M). Core profit slightly higher in 2024 (excluding adjustment for accruals in 2019) but also includes higher interest receipts. Cash balance is 76% higher than 2019 and the final dividend is 87% higher than 2019. Overall then, the broad picture looks better now than in 2019 with much stronger cash and a far higher dividend yield. In addition, the directors’ trading outlook is now more positive than it was in 2019. Yet, at that time, the share price reached the 230p area some four months after the 2019 results came out having continued to rise after the results. Then came Covid. It’s taken four years for ARC to resume a growth pattern in its numbers. Based on the above comparisons, the current share price would seem to have a long way to go. ARC’s enterprise value is around £10M now (market cap £17M less cash £7M held). In early 2020 when the share price hit 230p EV was around £26M (market cap £30M less cash £4M held). Share price now is 128p compared to 230p in early 2020. With sales and earnings in 2019 and 2024 both very similar and the business model virtually unchanged, it is clear that EV in 2024 is only around 40% of what it was 5 years ago. Yet, the business prospects are now higher and the dividend yield is also much higher than then. That alone should justify a higher share price than 2019. In fact it is nearly half of it. So, was it overvalued in 2019? Or have we got a long way to go for the share price to catch up? Two questions to ponder but it suggests the share price may have a way to go to meet the business prospects recently laid out by the directors. I’m hoping so. |
Posted at 02/9/2024 11:26 by bones I’ve bought back in today, mostly around 106, a few at 109.Seems a no brainer with upbeat commentary, £7M cash being half its market cap, bottom line profits £1M and rising, plus a handy dividend yield. |
Posted at 22/7/2024 15:49 by nocton May I ask how you came to those prices, boadicea? At the current price, ARC is on a p/e of 10.1 according to 'This is Money'. With a 20% forecast uplift in profit that would fall to 8.4. For this sort of share with reasonable growth prospects I should have thought a re-rating to at least a p/e of 12-14 was justified at the very least. So a price range of 114 to 133p would be more appropriate? |
Posted at 22/7/2024 08:47 by petewy Arcontech (AIM: ARC), the provider of products and services for real-time financial market data processing and trading announces that for the year ended 30 June 2024 (FY24) turnover is expected to be ahead of market expectations by approximately 4% as result of increased use of product by certain customers, whilst adjusted profit before tax is expected to be ahead by approximately 20%, as a result of the aforementioned increased product usage and certain planned staff costs only being incurred at the end of the financial year (FY24).Expectations for the current financial year (FY25) remain unchanged. |
Posted at 05/9/2023 11:50 by value hound Finncap note:Arcontech has reported encouraging FY23 results to June, with revenue of £2.7m, adj EBIT of £0.8m and net cash of £6.4m, and we upgrade FY24 net cash +3% to £6.8m while revising our adjusted EBIT. FY23 revenue of £2.7m is in line with expectations and 100% recurring, and reflects the strengthening relationships with the core tier 1 customer base through contract renewals into multi-year contracts. £0.8m of FY23 adj EBIT accounts for an accruals release of £0.1m previously excluded from forecasts, and – following delayed hires in FY23 – the sales team is now at full strength, with the strongest pipeline it has seen in recent years. At this point, we conservatively reiterate our FY24 revenue forecast of +2% yoy growth to £2.8m, and introduce FY25 revenue growth of +7% yoy to £3.0m. The annualised impact of the investment in sales then leads us to revise our FY24 adjusted EBIT to £0.5m, while we also include net interest income of £0.15m in FY24 and FY25. The combined impacts lead to FY24 net cash increasing by +3% to £6.8m then our new FY25 forecast of £7.2m, which provides the opportunity to continue to increase shareholder returns and/or evaluate attractive acquisitions. We expect revenue upside from new wins will benefit from strong operational gearing to profitability, noting some pipeline contracts have potential to exceed the entire revenue uplift currently forecast for FY24 and FY25, and we look forward to Arcontech announcing further client wins. We reiterate our 180p TP based on 34x our conservative FY25 EPS forecast, and at 89p, Arcontech is trading on 12-month forward multiples of 19.5x P/E, 7% EFCF yield, and an attractive 4% dividend yield. Changes to forecasts – We include a summary of the changes to forecasts on p7, where we conservatively leave FY24 revenue unchanged at 2% yoy growth and account for +22% yoy growth in adj opex to reflect the annualised impact of investment in sales ahead of client wins, supported by the strongest pipeline in recent years. In FY24 we now expect adj EBITDA of £0.6m -28% from £0.8m, adj EBIT of £0.5m -33% from £0.7m, and 4.4p adj dil EPS (previously 5.2p). In FY25 we expect conservative 7% revenue growth and an increase in adj EBIT margin to 19%, as a result of operational gearing from revenue growth. - Strong cash position can drive increased shareholder returns and/or M&A – Following net cash of £6.4m at FY23 and strong working capital management, we conservatively increase our FY24 net cash to £6.8m and introduce FY25 net cash of £7.2m, following strong EFCF of £0.8m (FY24) and £0.9m (FY25) and 5% DPS growth in both years. - Arcontech has excellent potential to capitalise on its strong pipeline – Arcontech benefits from the quality of its software, its strong relationships with tier 1 institutions, and c100% recurring licence fee revenue. As market conditions for new sales continue to improve, we expect the investment in its technology and salesforce will generate operating leverage to profitability from new and existing clients. The strong cash position provides flexibility to continue to invest in the potential of its platform, increase shareholder returns, and/or benefit from M&A. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
